Why was Drug Supply Chain Security Act enacted?
A lack of traceability in the drug supply chain is a problem for companies as much as it is for consumers and the FDA. Congress in November 2013 moved to strengthen this supply chain through the enactment of the Drug Supply Chain Security Act, which is part of the Drug Quality and Security Act (DQSA).
To help ensure the safety and security of the pharmaceutical supply chain in the U.S., DSCSA requirements aim to deter, detect, and remove potentially dangerous drugs from the supply chain.
This will enhance FDA's ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. These requirements will also improve detection and removal of potentially dangerous drugs from the drug supply chain to protect U.S. consumers.
The bill was written in response to the New England Compounding Center meningitis outbreak that took place in 2012, which killed 64 people. The bill was signed by President Obama on November 27, 2013.
Quarantine and investigate suspect prescription drugs to determine if they are illegitimate; and. If they are illegitimate, pharmacies should work with the manufacturer and take specific steps to ensure patients do not receive the illegitimate drugs.
Title II of the Drug Quality and Security Act, the DSCSA, was signed into law by President Barack Obama on November 27, 2013, with a phased implementation over 10 years eventually leading to a fully interoperable, electronic system for the tracking and tracing of products throughout the supply chain.
FDA-2020-N-1663) as required by the Drug Supply Chain Security Act (DSCSA). The proposed rule, when finalized, would provide greater assurance that supply chain participants are sufficiently vetted and qualified to distribute prescription drugs, further strengthening the supply chain.
Those DSCSA requirements are scheduled to change on November 27, 2023, and will include requiring trading partners to provide, receive and maintain documentation about products and ownership only electronically.
In general, over-the-counter drugs, medical devices, and drugs for animals are exempt from the act.
THE DSCSA'S FINAL IMPLEMENTATION PHASE
Create an end-to-end verification system to validate the legitimacy of a drug, all the way down to the package level.
What is the name of the first drug act passed by the US government?
Since 1879, nearly 100 bills had been introduced in Congress to regulate food and drugs; on 30 June 1906 President Roosevelt signed the Food and Drugs Act, known simply as the Wiley Act, a pillar of the Progressive era.
1906 The original Food and Drugs Act is passed by Congress on June 30 and signed by President Theodore Roosevelt. It prohibits interstate commerce in misbranded and adulterated foods, drinks and drugs.
Introduction. Enacted in 2013, the Drug Supply Chain Security Act (DSCSA) outlines steps to build an electronic, interoperable system to help identify and trace certain prescription drugs as they are distributed in the United States by 2023.
Drugs are manufactured at production sites. They are then transferred to wholesale distributors. The pharmaceuticals are stocked at various types of pharmacies, including retail and mail-order. Pharmacy benefit management companies negotiate prices and process drugs through quality and utilization management checks.
The product identifier requires the SNI, lot number, and expiration date. The drug package label must include the product identifier information (i.e., the NDC, serial number, lot number, and expiration date) in both the human- readable form and the machine-readable, 2D data matrix barcode format.
Pharmacists, or “dispensers” under the DSCSA, must know their responsibilities under the law to protect patients from receiving harmful drug products. The DSCSA includes requirements that pharmacies must follow to protect patients from receiving harmful drugs, such as counterfeit or other illegitimate drugs.
3204, the Drug Quality and Security Act. The Drug Quality and Security Act has two distinct and independent acts: 1) the Compounding Quality Act and 2) the Drug Supply Chain Security Act.
The Federal Food, Drug, and Cosmetic (FDC) Act of 1938 is passed by Congress, containing new provisions: Extending control to cosmetics and therapeutic devices. Requiring new drugs to be shown safe before marketing-starting a new system of drug regulation.
The Controlled Substances Act (CSA) places all substances which were in some manner regulated under existing federal law into one of five schedules. This placement is based upon the substance's medical use, potential for abuse, and safety or dependence liability.
FDA pushes Enforcement of DSCSA deadline to November 2024
The change in deadline does not come as a surprise as industry readiness has been a concern and a topic of conversation amongst pharmaceutical trading partners.
Has DSCSA been delayed?
The looming Nov. 27 deadline for enforcement of the Drug Supply Chain Security Act is delayed one year until November 27, 2024, giving drug manufacturers and distributors more time to prepare for compliance, according to an August regulatory guidance from the Food and Drug Administration.
How does the law affect physician offices or clinics? Physician offices or clinics licensed as a practitioner are included in the definition of dispenser under the DSCSA. But there is an exemption for licensed health care practitioners authorized to prescribe or administer medication under state law.
Pharmaceutical supply chain management consists of the strategic coordination of the entire value-added process of a product (pharma value chain) and the logistics. This refers to the collaboration between manufacturers, suppliers, distributors, business partners, and consumers from procurement to final delivery.
FDA regulates the sale of medical device products (including diagnostic tests) in the U.S. and monitors the safety of all regulated medical products.
“Return” as used under the DSCSA means providing product to the authorized immediate trading partner from whom such product was purchased or received, or to a returns processor or reverse logistics provider for handling of such product.
References
- https://pqri.org/wp-content/uploads/2015/10/01-How-to-identify-CQA-CPP-CMA-Final.pdf
- https://en.wikipedia.org/wiki/Food_and_Drug_Administration
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609997/
- https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q8-q9-q10-questions-and-answers-appendix-qas-training-sessions-q8-q9-q10-points-consider
- https://www.nature.com/articles/d41573-023-00001-3
- https://go.drugbank.com/stats
- https://www.americanpharmaceuticalreview.com/Featured-Articles/359768-Critical-Quality-Attributes-Assessment-and-Testing-Strategy-for-Biotherapeutics-Development/
- https://blog.perkinelmer.com/posts/the-four-pillars-of-critical-quality-attributes/
- https://www.usp.org/sites/default/files/fda-exhibit/legislation/1938.html
- https://www.fda.gov/about-fda/fda-history/milestones-us-food-and-drug-law
- https://www.whitehouse.gov/about-the-white-house/our-government/the-legislative-branch/
- https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/pharmacists-utilize-dscsa-requirements-protect-your-patients
- https://www.fda.gov/about-fda/fda-organization/fda-organization-charts
- https://oig.hhs.gov/oei/reports/oei-03-90-02300.pdf
- https://www.ncbi.nlm.nih.gov/books/NBK236093/
- https://medium.com/@sajiveva1112000/understanding-the-four-types-of-quality-assurance-for-exceptional-results-bef3168060fc
- https://www.bio.org/media/press-release/new-study-shows-rate-drug-approvals-lower-previously-reported
- https://www.pharmacytimes.com/view/pharmacies-gear-up-for-dscsa-interoperability-go-live-deadline
- https://www.linkedin.com/pulse/fda-delays-dscsa-drug-supply-chain-security
- https://www.fda.gov/media/104094/download
- https://www.fda.gov/media/148197/download
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293739/
- https://www.usa.gov/agencies/food-and-drug-administration
- https://www.fda.gov/medical-devices/home-use-devices/fdas-role-regulating-medical-devices
- https://pubmed.ncbi.nlm.nih.gov/21698778/
- https://www.nichd.nih.gov/health/topics/pharma/conditioninfo/approval
- https://www.fiercepharma.com/pharma/from-old-behemoth-lipitor-to-new-king-humira-u-s-best-selling-drugs-over-25-years
- https://constitutioncenter.org/the-constitution/articles/article-i/clauses/752
- https://www.hamiltoncompany.com/process-analytics/process-analytical-technology/critical-quality-attributes
- https://www.eurofinsus.com/food-testing/resources/usda-vs-fda-food-labeling/
- https://www.statnews.com/2020/11/03/should-fda-be-independent/
- https://library.weill.cornell.edu/about-us/snake%C2%A0oil%C2%A0-social%C2%A0media-drug-advertising-your-health/food-and-drug-administration-continued
- https://www.fda.gov/drugs/enforcement-activities-fda/unapproved-drugs
- https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/fdas-origin
- https://www.fda.gov/industry/fda-user-fee-programs/fda-user-fees-explained
- https://www.fda.gov/about-fda/fda-basics/what-does-fda-regulate
- https://crstoday.com/articles/2011-oct/a-brief-history-of-the-fda
- https://phrma.org/Scientific-Innovation/In-The-Pipeline
- https://www.fda.gov/media/164429/download
- https://rarediseases.org/wp-content/uploads/2014/12/NORD-TimeLine.pdf
- https://www.svarlifescience.com/services/bioanalytical-services/potency-testing
- https://www.visitthecapitol.gov/exhibitions/congress-and-progressive-era/pure-food-and-drug-act
- https://www.cardinalhealth.com/content/dam/corp/web/documents/brochure/CardinalHealth-DrugTracingFAQsCustomers.pdf
- https://landmarkrecovery.com/history-of-us-drug-enforcement/
- https://www.law.cornell.edu/wex/commerce_clause
- https://www.fda.gov/about-fda/fda-basics/when-and-why-was-fda-formed
- https://www.azonano.com/article.aspx?ArticleID=6283
- https://www.supplychaindive.com/news/pharmaceutical-traceability-law-DSCSA-delayed-2024-healthcare-supply-chain/693431/
- https://www.qualifyze.com/resources/blog/what-is-the-pharmaceutical-supply-chain/
- https://www.fda.gov/drugs/drug-safety-and-availability/dscsa-compliance-policies-establish-1-year-stabilization-period-implementing-electronic-systems
- https://en.wikipedia.org/wiki/Office_of_Criminal_Investigations
- https://www.nature.com/articles/s41591-020-01200-w
- https://blog.tracktracerx.com/will-affected-dscsa
- https://www.dea.gov/drug-information/csa
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070262/
- https://alirahealth.com/education-hub/critical-quality-attributes-for-drug-products/
- https://pubmed.ncbi.nlm.nih.gov/665689/
- https://www.upm-inc.com/why-is-pharmaceutical-quality-assurance-important
- https://ncs-conference.org/wp-content/uploads/2022/12/Lamerz-D3-20m-V2-An-update-on-Roche_s-experience-with-the-Impact-Ratio-year-six.pdf
- https://www.fda.gov/regulatory-information/fda-rules-and-regulations
- https://www.fda.gov/files/about%20fda/published/2017-New-Drug-Therapy-Approvals-Report.pdf
- https://www.fda.gov/about-fda/what-we-do
- https://www.fda.gov/about-fda/histories-fda-regulated-products/history-drug-regulation
- https://www.dda.gov.np/content/about-us
- https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/part-i-1906-food-and-drugs-act-and-its-enforcement
- https://www.fda.gov/about-fda/economics-staff/fda-glance
- https://www.goodrx.com/drugs/medication-basics/what-are-unapproved-drugs
- https://www.understandinganimalresearch.org.uk/news/why-do-90-of-new-drugs-fail
- https://www.coursera.org/articles/quality-assurance-vs-quality-control
- https://www.fda.gov/federal-state-local-tribal-and-territorial-officials/fda-contacts-regulatory-partners
- https://www.federalregister.gov/agencies/drug-enforcement-administration
- https://www.fda.gov/media/115824/download
- https://www.optelgroup.com/en/blog/drug-supply-chain-security-act-dscsa/
- https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa
- https://www.altersis-performance.com/continuous-quality-assurance/
- https://www.ncbi.nlm.nih.gov/books/NBK582130/
- https://www.fda.gov/about-fda/fda-organization
- https://www.bu.edu/articles/2023/judge-ruling-abortion-pill-impact-fda-approved-drugs/
- https://www.sqmgroup.com/resources/library/blog/customer-quality-assurance-cqa
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866602/
- https://pubmed.ncbi.nlm.nih.gov/31793428/
- https://www.cbo.gov/publication/57126
- https://slcontrols.com/qbd-cqa-cpp-pat-understanding-process-validation-terminology/
- https://finance.yahoo.com/news/top-16-medicine-producing-countries-120134464.html
- https://www.asq.org/cert/resource/pdf/certification/FactSheets/CQA%20Fact%20Sheet.pdf
- https://scholarship.law.campbell.edu/cgi/viewcontent.cgi?article=1222&context=clr
- https://www.lilly.com/news/stories/accelerated-approval-get-needed-treatments-patients
- https://www.fda.gov/
- https://www.fda.gov/media/133830/download
- https://www.fda.gov/about-fda/fda-basics/fda-fundamentals
- https://en.wikipedia.org/wiki/History_of_the_Food_and_Drug_Administration
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151195/
- https://lifesciencesintelligence.com/features/the-top-5-most-expensive-fda-approved-gene-therapies
- https://www.fda.gov/drugs/development-approval-process-drugs
- https://www.quora.com/Is-the-FDA-constitutional
- https://www.fda.gov/media/109482/download
- https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/fda-related-laws-regulations-and-guidances
- https://www.meps.ahrq.gov/data_files/publications/st245/stat245.pdf
- https://www.fda.gov/media/151975/download
- https://www.hamiltoncompany.com/process-analytics/process-analytical-technology/critical-process-parameters
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911992/
- https://mitsloan.mit.edu/press/measuring-risks-and-rewards-drug-development-new-research-mit-shows-success-rates-clinical-trials-are-higher-previously-thought
- https://crsreports.congress.gov/product/pdf/R/R44782
- https://www.wsj.com/us-news/oregon-decriminalized-hard-drugs-it-isnt-working-78ee7476
- https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/pure-food-and-drug-act
- https://www.arlok.com/news/stability-versus-potency-testing
- https://www.fda.gov/about-fda/fda-history-exhibits/80-years-federal-food-drug-and-cosmetic-act
- https://press.princeton.edu/books/paperback/9780691141800/reputation-and-power
- https://oig.hhs.gov/oei/reports/oei-09-00-00380.pdf
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066341/
- https://en.wikipedia.org/wiki/Drug_Quality_and_Security_Act
- https://www.mcguirewoods.com/client-resources/alerts/2013/12/drug-quality-and-security-act/
- https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/fda-announces-proposed-rule-national-standards-licensure-wholesale-drug-distributors-and-third-party
- https://en.wikipedia.org/wiki/An_act_to_regulate_the_time_and_manner_of_administering_certain_oaths
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907423/
- https://www.fda.gov/about-fda/office-policy-legislation-and-international-affairs/office-legislation
- https://clincalc.com/DrugStats/Top300Drugs.aspx
- https://www.fda.gov/about-fda/changes-science-law-and-regulatory-authorities/fdas-legal-authority
- https://blog.tracktracerx.com/hda-updates-their-q/a-for-the-dscsa
- https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/what-do-i-need-know-about-supply-chain-security-requirements-under-drug-supply-chain-security-act
- https://pubmed.ncbi.nlm.nih.gov/34662058/
- https://www.fda.gov/about-fda/fda-commissioner
- https://study.com/learn/lesson/pharmacology-terms-potency-efficacy-affinity.html
- https://510kfda.com/pages/fda-510k-costs
- https://www.sciencedirect.com/topics/engineering/key-process-parameter
- https://pharmanewsintel.com/news/fundamentals-of-the-pharmaceutical-supply-chain
- https://www.fda.gov/media/116304/download
